Penetrium Bioscience Inc. (KOSDAQ:187660)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,510
-750 (-5.66%)
At close: Apr 28, 2026

Penetrium Bioscience Company Description

Penetrium Bioscience Inc., a contract research organization, provides clinical-related professional services for customer requirements in South Korea.

The company offers clinical development services, such as medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs.

It also provides pharmacovigilance services, which include case processing and safety reporting, safety and risk management plans, aggregate reporting, literature screening, and medical device vigilance; and quality assurance services.

The company was formerly known as Hyundai ADM Bio Inc. and changed its name to Penetrium Bioscience Inc. in March 2026.

Penetrium Bioscience Inc. was founded in 2003 and is based in Seoul, South Korea.

Penetrium Bioscience Inc.
Country South Korea
Founded 2003
Industry Commercial Physical and Biological Research
Employees 160
CEO Hyun-woo Kim

Contact Details

Address:
#603, 166 Magokdong-ro
Seoul, 07790
South Korea
Phone 82 2 730 1457
Website penetriumbio.com

Stock Details

Ticker Symbol 187660
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 8731

Key Executives

Name Position
Hyun-woo Kim Chief Executive Officer
Dohyeong Na Chief Financial Officer